Cargando…
Elesclomol induces copper‐dependent ferroptosis in colorectal cancer cells via degradation of ATP7A
Cancer cells reprogram their copper metabolism to adapt to adverse microenvironments, such as oxidative stress. The copper chelator elesclomol has been reported to have considerable anticancer efficacy, but the underlying mechanisms remain largely unknown. In this study, we found that elesclomol‐med...
Autores principales: | Gao, Wei, Huang, Zhao, Duan, Jiufei, Nice, Edouard C., Lin, Jie, Huang, Canhua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637554/ https://www.ncbi.nlm.nih.gov/pubmed/34390123 http://dx.doi.org/10.1002/1878-0261.13079 |
Ejemplares similares
-
Current advancements and future perspectives of long noncoding RNAs in lipid metabolism and signaling
por: Duan, Jiufei, et al.
Publicado: (2022) -
FDX1-dependent and independent mechanisms of elesclomol-mediated intracellular copper delivery
por: Zulkifli, Mohammad, et al.
Publicado: (2023) -
Elesclomol restores mitochondrial function in genetic models of copper deficiency
por: Soma, Shivatheja, et al.
Publicado: (2018) -
Oral Elesclomol Treatment Alleviates Copper Deficiency in Animal Models
por: Yuan, Sai, et al.
Publicado: (2022) -
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy
por: Zheng, Peijie, et al.
Publicado: (2022)